Literature DB >> 29048771

Catecholaminergic polymorphic ventricular tachycardia, an update.

Andrés R Pérez-Riera1, Raimundo Barbosa-Barros2, Marianne P C de Rezende Barbosa1, Rodrigo Daminello-Raimundo1, Augusto A de Lucca1, Luiz C de Abreu1.   

Abstract

Catecholaminergic polymorphic ventricular tachycardia is a rare devastating lethal inherited disorder or sporadic cardiac ion channelopathy characterized by unexplained syncopal episodes, and/or sudden cardiac death (SCD), aborted SCD (ASCD), or sudden cardiac arrest (SCA) observed in children, adolescents, and young adults without structural heart disease, consequence of adrenergically mediated arrhythmias: exercise-induced, by acute emotional stress, atrial pacing, or β-stimulant infusion, even when the electrocardiogram is normal. The entity is difficult to diagnose in the emergency department, given the range of presentations; thus, a familiarity with and high index of suspicion for this pathology are crucial. Furthermore, recognition of the characteristic findings and knowledge of the management of symptomatic patients are necessary, given the risk of arrhythmia recurrence and SCA. In this review, we will discuss the concept, epidemiology, genetic background, genetic subtypes, clinical presentation, electrocardiographic features, diagnosis criteria, differential diagnosis, and management.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  catecholaminergic polymorphic ventricular tachycardia; channelopathies; normal structural heart; sudden cardiac death/arrest

Mesh:

Year:  2017        PMID: 29048771      PMCID: PMC6931575          DOI: 10.1111/anec.12512

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  51 in total

1.  Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals.

Authors:  Andrew P Landstrom; Andrew L Dailey-Schwartz; Jill A Rosenfeld; Yaping Yang; Margaret J McLean; Christina Y Miyake; Santiago O Valdes; Yuxin Fan; Hugh D Allen; Daniel J Penny; Jeffrey J Kim
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-04

2.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).

Authors:  N Tiso; D A Stephan; A Nava; A Bagattin; J M Devaney; F Stanchi; G Larderet; B Brahmbhatt; K Brown; B Bauce; M Muriago; C Basso; G Thiene; G A Danieli; A Rampazzo
Journal:  Hum Mol Genet       Date:  2001-02-01       Impact factor: 6.150

3.  RyR2R420Q catecholaminergic polymorphic ventricular tachycardia mutation induces bradycardia by disturbing the coupled clock pacemaker mechanism.

Authors:  Yue Yi Wang; Pietro Mesirca; Elena Marqués-Sulé; Alexandra Zahradnikova; Olivier Villejoubert; Pilar D'Ocon; Cristina Ruiz; Diana Domingo; Esther Zorio; Matteo E Mangoni; Jean-Pierre Benitah; Ana María Gómez
Journal:  JCI Insight       Date:  2017-04-20

4.  Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapy.

Authors:  Guoxin Kang; Steven F Giovannone; Nian Liu; Fang-Yu Liu; Jie Zhang; Silvia G Priori; Glenn I Fishman
Journal:  Circ Res       Date:  2010-07-01       Impact factor: 17.367

Review 5.  Channelopathies, genetic testing and risk stratification.

Authors:  Arthur A M Wilde; Ahmad Amin
Journal:  Int J Cardiol       Date:  2017-03-18       Impact factor: 4.164

6.  Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.

Authors:  Prince J Kannankeril; Jeremy P Moore; Marina Cerrone; Silvia G Priori; Naomi J Kertesz; Pamela S Ro; Anjan S Batra; Elizabeth S Kaufman; David L Fairbrother; Elizabeth V Saarel; Susan P Etheridge; Ronald J Kanter; Michael P Carboni; Matthew V Dzurik; Darlene Fountain; Heidi Chen; E Wesley Ely; Dan M Roden; Bjorn C Knollmann
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

7.  Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.

Authors:  Thomas M Roston; Jeffrey M Vinocur; Kathleen R Maginot; Saira Mohammed; Jack C Salerno; Susan P Etheridge; Mitchell Cohen; Robert M Hamilton; Andreas Pflaumer; Ronald J Kanter; James E Potts; Martin J LaPage; Kathryn K Collins; Roman A Gebauer; Joel D Temple; Anjan S Batra; Christopher Erickson; Maria Miszczak-Knecht; Peter Kubuš; Yaniv Bar-Cohen; Michal Kantoch; Vincent C Thomas; Gabriele Hessling; Chris Anderson; Ming-Lon Young; Michel Cabrera Ortega; Yung R Lau; Christopher L Johnsrude; Anne Fournier; Prince J Kannankeril; Shubhayan Sanatani
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-02-24

8.  A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1.

Authors:  Yosuke Kokunai; Tomohiko Nakata; Mitsuru Furuta; Souhei Sakata; Hiromi Kimura; Takeshi Aiba; Masao Yoshinaga; Yusuke Osaki; Masayuki Nakamori; Hideki Itoh; Takako Sato; Tomoya Kubota; Kazushige Kadota; Katsuro Shindo; Hideki Mochizuki; Wataru Shimizu; Minoru Horie; Yasushi Okamura; Kinji Ohno; Masanori P Takahashi
Journal:  Neurology       Date:  2014-02-26       Impact factor: 9.910

9.  Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.

Authors:  Mette Nyegaard; Michael T Overgaard; Mads T Søndergaard; Marta Vranas; Elijah R Behr; Lasse L Hildebrandt; Jacob Lund; Paula L Hedley; A John Camm; Göran Wettrell; Inger Fosdal; Michael Christiansen; Anders D Børglum
Journal:  Am J Hum Genet       Date:  2012-10-05       Impact factor: 11.025

10.  Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.

Authors:  Peter J Schwartz; Silvia G Priori; Marina Cerrone; Carla Spazzolini; Attilio Odero; Carlo Napolitano; Raffaella Bloise; Gaetano M De Ferrari; Catherine Klersy; Arthur J Moss; Wojciech Zareba; Jennifer L Robinson; W Jackson Hall; Paul A Brink; Lauri Toivonen; Andrew E Epstein; Cuilan Li; Dayi Hu
Journal:  Circulation       Date:  2004-03-29       Impact factor: 29.690

View more
  10 in total

1.  The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.

Authors:  Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

Review 2.  Catecholaminergic polymorphic ventricular tachycardia, an update.

Authors:  Andrés R Pérez-Riera; Raimundo Barbosa-Barros; Marianne P C de Rezende Barbosa; Rodrigo Daminello-Raimundo; Augusto A de Lucca; Luiz C de Abreu
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-10-19       Impact factor: 1.468

3.  Compendium of causative genes and their encoded proteins for common monogenic disorders.

Authors:  Tucker L Apgar; Charles R Sanders
Journal:  Protein Sci       Date:  2021-09-21       Impact factor: 6.993

4.  Impaired Dynamic Sarcoplasmic Reticulum Ca Buffering in Autosomal Dominant CPVT2.

Authors:  Matthew J Wleklinski; Dmytro O Kryshtal; Kyungsoo Kim; Shan S Parikh; Daniel J Blackwell; Isabelle Marty; V Ramesh Iyer; Bjӧrn C Knollmann
Journal:  Circ Res       Date:  2022-09-14       Impact factor: 23.213

5.  Molecular basis for gating of cardiac ryanodine receptor explains the mechanisms for gain- and loss-of function mutations.

Authors:  Takuya Kobayashi; Akihisa Tsutsumi; Nagomi Kurebayashi; Kei Saito; Masami Kodama; Takashi Sakurai; Masahide Kikkawa; Takashi Murayama; Haruo Ogawa
Journal:  Nat Commun       Date:  2022-05-20       Impact factor: 17.694

6.  Identifying Features of Cardiac Disease Phenotypes Based on Mechanical Function in a Catecholaminergic Polymorphic Ventricular Tachycardia Model.

Authors:  A Stempien; M Josvai; W J de Lange; J J Hernandez; J Notbohm; T J Kamp; H H Valdivia; L L Eckhardt; K R Maginot; J C Ralphe; W C Crone
Journal:  Front Bioeng Biotechnol       Date:  2022-05-10

Review 7.  Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Matthew J Wleklinski; Prince J Kannankeril; Bjӧrn C Knollmann
Journal:  J Physiol       Date:  2020-04-27       Impact factor: 5.182

8.  Biophysical Characterization of a Novel SCN5A Mutation Associated With an Atypical Phenotype of Atrial and Ventricular Arrhythmias and Sudden Death.

Authors:  Mohammad-Reza Ghovanloo; Joseph Atallah; Carolina A Escudero; Peter C Ruben
Journal:  Front Physiol       Date:  2020-12-22       Impact factor: 4.566

Review 9.  Clinical Genetics of Inherited Arrhythmogenic Disease in the Pediatric Population.

Authors:  Estefanía Martínez-Barrios; Sergi Cesar; José Cruzalegui; Clara Hernandez; Elena Arbelo; Victoria Fiol; Josep Brugada; Ramon Brugada; Oscar Campuzano; Georgia Sarquella-Brugada
Journal:  Biomedicines       Date:  2022-01-05

Review 10.  The Hidden Fragility in the Heart of the Athletes: A Review of Genetic Biomarkers.

Authors:  Ferdinando Barretta; Bruno Mirra; Emanuele Monda; Martina Caiazza; Barbara Lombardo; Nadia Tinto; Olga Scudiero; Giulia Frisso; Cristina Mazzaccara
Journal:  Int J Mol Sci       Date:  2020-09-12       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.